Medical and Scientific Team
Dr. Sherif Ibrahim, MD, PhD.
Founder and Chief Medical Officer
and lead Pathologist is recognized nationally as an expert in the field of Hematopathology and Flow Cytometric Diagnoses.Dr. Ibrahim previously held several positions at NYU School of Medicine and Hospitals (2001-2017), including Adjunct Professor, Director of Hematopathology/Molecular Pathology and Director of the Hematopathology Fellowship Program. He also served as a Hematopathology Consultant at Memorial Sloan-Kettering Cancer Center from 2008 to 2017.
He performed his Hematopathology Fellowship at the M D Anderson Cancer Center.
Dr. Ibrahim contributed to the scientific literature in the field of Hematology and Oncology more than 60 peer-reviewed articles and several book chapters and presentations in Hematopathology and Molecular Pathology.
Dr. Ibrahim is routinely engaged by other pathologists and physicians to render second opinions on the most difficult to diagnose leukemia and lymphoma cases.
Dr. Sergej Konoplev
Board Certified in Hematopathology, Anatomic Pathology and Clinical Pathology
Dr. Sergej Konoplev served as Professor of the Department of Hematology- The University of Texas MD Anderson Cancer Center in Houston, TX. He received his MD at St. Petersburg State I.P. Pavlov Medical University and his PhD at Federal Institute of Hematology and Blood Transfusion, St. Petersburg, Russian Federation. He continued his clinical residency in Internal Medicine from I.P. Pavlov State Medical Institute, St. Petersburg. After coming to the United States of America, Dr Sergej Konoplev completed his postdoctoral fellowship at The University of Texas MD Anderson Cancer Center, his residency in Anatomic and Clinical Pathology at the University of Cincinnati, Cincinnati, OH and The University of Texas Southwestern Medical Center in 2004. He went on to complete his fellowship in Hematopathology and Advanced Hematopathology at the University of Texas MD Anderson Cancer Center. Throughout his career, he has spent his time researching, mentoring, practicing and has
been recognized for his contribution on over 150 publications.
Dr. Sarah Chaudhary, MD.
Board Certified Hematopathologist
who has been at Cairo Diagnostics since August 2016.
Dr Chaudhary completed her AP/CP residency at Baystate Medical Center in Springfield, MA and pursued her passion of hematopathology by completing her fellowship at NewYork-Presbyterian/Columbia University Medical Center.
Since joining Cairo Diagnostics, Dr. Chaudhary has tremendous experience in Hematopathology and Flow Cytometry by seeing a large number of cases including many complex/rare entities.
Dr. Bixia Xiang, PhD, FACMGG.
Director of Cytogenetics and PGT-A
and the Director of PGT-A Dept. of Cairo Diagnostics Laboratory.
Dr. Xiang previously held several positions at NexGenomics, HRC fertility (2015-2019), Ecahn School of Medcine at Mount Sinai (2015-2018), BayCare Medical Group (2014-2015), City of Hope Medical Center (2010-2013), University of Miami Medical center (2008-2010), Including Associate Professor, Director of Cytogenetics and Cytogenomics, Director of PGT-A. She has been served as a Medical Genetics Consultant at BGI since 2017.
Dr. Xiang is an ABMGG Board-Certified Cytogeneticist with over ten years’ experience in Cytogenetics of Oncology and Hematology and is a recognized expert in the field of arrayCGH clinical application on both Constitutional (Prenatal and Postnatal) and Cancer fields. She performed her Molecular Cytogenetics Fellowship at School of Medicine, Yale University.
Dr. Xiang contributed to the scientific literature in the field of Molecular Cytogenetics more than 40 peer-reviewed articles and presentations; Dr. Xiang is also an Ad Hoc Reviewer for several Molecular Cytogenetics journals.
Dr. Sung-hee Oh
Board Certified in Hematopathology, Clinical Pathology and Molecular Genetic Pathology